结直肠癌统计,2017年
美国癌症协会每3年更新结直肠癌发病率、生存率和死亡率及趋势。2000至2013年,≥50岁成人发病率下降32%,<50岁成人发病率上升22%;2000至2014年,≥50岁死亡率下降34%,<50岁死亡率上升13%。
要点
- ≥50岁成人结直肠癌发病率下降32%,但<50岁成人发病率上升22%。
- ≥50岁成人结直肠癌死亡率下降34%,但<50岁成人死亡率上升13%。
- 年轻成人结直肠癌增加的原因需研究阐明。
核心结论
- 通过提高50岁(平均风险)或更早(如结直肠癌/进展期腺瘤家族史)开始筛查的启动率以及消除高质量治疗的差异,可加速结直肠癌防治进展;此外,需要研究阐明年轻成人结直肠癌增加的原因。
研究设计与样本
- 美国癌症协会每3年提供结直肠癌发病率、生存率和死亡率及趋势更新;发病率数据截至2013年来自监测、流行病学和最终结果项目、国家癌症登记项目及北美中央癌症登记协会,死亡率数据截至2014年来自国家卫生统计中心。
主要发现
- 结直肠癌发病率在阿拉斯加原住民和黑人中最高,在亚洲/太平洋岛民中最低,男性比女性高30%至40%。
- 2000至2013年间,≥50岁成人结直肠癌发病率下降32%,其中≥65岁者远端肿瘤下降幅度最大(发病率比[IRR] 0.50;95%置信区间[95% CI] 0.48-0.52),50至64岁者直肠肿瘤下降幅度最小(男性IRR 0.91;95% CI 0.85-0.96;女性IRR 1.00;95% CI 0.93-1.08)。
- 2009至2013年间,≥50岁者结直肠癌总体发病率除阿肯色州外各州均下降,其中7个州年下降幅度超过5%;但50至64岁者直肠肿瘤发病率在多数州保持稳定。
- 2000至2013年间,<50岁成人结直肠癌发病率上升22%,仅由远端结肠肿瘤(IRR 1.24;95% CI 1.13-1.35)和直肠肿瘤(IRR 1.22;95% CI 1.13-1.31)驱动。
- 2000至2014年间,≥50岁者结直肠癌死亡率下降34%,但<50岁者死亡率上升13%。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Colorectal cancer (CRC) is one of the most common malignancies in the United States. Every 3 years, the American Cancer Society provides an update of CRC incidence, survival, and mortality rates and trends. Incidence data through 2013 were provided by the Surveillance, Epidemiology, and End Results program, the National Program of Cancer Registries, and the North American Association of Central Cancer Registries. Mortality data through 2014 were provided by the National Center for Health Statistics. CRC incidence rates are highest in Alaska Natives and blacks and lowest in Asian/Pacific Islanders, and they are 30% to 40% higher in men than in women. Recent temporal patterns are generally similar by race and sex, but differ by age. Between 2000 and 2013, incidence rates in adults aged ≥50 years declined by 32%, with the drop largest for distal tumors in people aged ≥65 years (incidence rate ratio [IRR], 0.50; 95% confidence interval [95% CI], 0.48-0.52) and smallest for rectal tumors in ages 50 to 64 years (male IRR, 0.91; 95% CI, 0.85-0.96; female IRR, 1.00; 95% CI, 0.93-1.08). Overall CRC incidence in individuals ages ≥50 years declined from 2009 to 2013 in every state except Arkansas, with the decrease exceeding 5% annually in 7 states; however, rectal tumor incidence in those ages 50 to 64 years was stable in most states. Among adults aged <50 years, CRC incidence rates increased by 22% from 2000 to 2013, driven solely by tumors in the distal colon (IRR, 1.24; 95% CI, 1.13-1.35) and rectum (IRR, 1.22; 95% CI, 1.13-1.31). Similar to incidence patterns, CRC death rates decreased by 34% among individuals aged ≥50 years during 2000 through 2014, but increased by 13% in those aged <50 years. Progress against CRC can be accelerated by increasing initiation of screening at age 50 years (average risk) or earlier (eg, family history of CRC/advanced adenomas) and eliminating disparities in high-quality treatment. In addition, research is needed to elucidate causes for increasing CRC in young adults. CA Cancer J Clin 2017. © 2017 American Cancer Society. CA Cancer J Clin 2017;67:177-193. © 2017 American Cancer Society.
引用
- Siegel RL, Miller KD, Fedewa SA, et al. Colorectal cancer statistics, 2017. CA Cancer J Clin. 2017. PMID: 28248415. doi:10.3322/caac.21395
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。